Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001935979-25-000022
Filing Date
2025-03-18
Accepted
2025-03-18 16:47:10
Documents
20
Period of Report
2025-05-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A bhvn-20250318.htm   iXBRL DEF 14A 715898
3 bhvn-20250318_g1.jpg GRAPHIC 20335
4 bhvn-20250318_g2.jpg GRAPHIC 84292
5 bhvn-20250318_g3.jpg GRAPHIC 84397
6 bhvn-20250318_g4.jpg GRAPHIC 151141
7 bhvn-20250318_g5.jpg GRAPHIC 217151
8 bhvn-20250318_g6.jpg GRAPHIC 476863
9 bhvn-20250318_g7.jpg GRAPHIC 173479
  Complete submission text file 0001935979-25-000022.txt   4092656

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20250318.xsd EX-101.SCH 936
22 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20250318_htm.xml XML 87258
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41477 | Film No.: 25749131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)